Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors
暂无分享,去创建一个
J. Minna | K. Huffman | B. Drapkin | Shreoshi Pal Choudhuri | Xu-dong Wang | Chiho Kim | Yikai Luo | Seoyeon Jang | Zhenzhen Zi | Qing Ding | Shuai Wang | Han Liang | Yonghao Yu | Jiwoong Kim | Peng Li | Zhengshuai Liu | Jianwei Hao | Sofia del Rio | Ling Cai